&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-05-17, 00:38

Valeura Announces Voting Results

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-05-16, 05:12

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-05-13, 20:20

VEEA® Announces Acquisition of AI-Enabled Smart Spaces Provider Crowdkeep

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-05-13, 07:00

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-05-08, 02:17

WillScot Announces Partnership with Penske Entertainment Corp. to Sponsor NTT INDYCAR SERIES, Indianapolis Motor Speedway

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-05-07, 22:00

Zoom and ServiceNow Announce Strategic Integration to Elevate Customer and Employee Experiences

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-05-06, 19:00

Boehringer Ingelheim starts Phase II study of its potential first-in-class oral compound as a treatment for Geographic Atropy

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-05-05, 18:49

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-05-02, 15:59

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-04-29, 19:00

Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders

Notified -

Popular Posts